RISS Block for Enhanced Recovery After Video-Assisted Thoracoscopic Surgery
A Prospective Randomized Controlled Trial Evaluating the Efficacy and Safety of Ultrasound-Guided Rhomboid Intercostal and Subserratus Plane Block for Enhanced Recovery After Video-Assisted Thoracoscopic Surgery
1 other identifier
interventional
90
1 country
1
Brief Summary
This prospective randomized controlled trial evaluates the efficacy and safety of ultrasound-guided rhomboid intercostal and subserratus plane (RISS) block for postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery (VATS). Postoperative pain after VATS can impair respiratory function, delay mobilization, and increase opioid consumption. Although several regional anesthesia techniques are available, the optimal analgesic strategy remains under investigation. The RISS block is a novel fascial plane block that may provide effective thoracic analgesia while minimizing opioid-related adverse effects. A total of 90 adult patients scheduled for elective VATS will be randomly assigned to receive either ultrasound-guided RISS block combined with general anesthesia or general anesthesia alone. The primary outcomes include postoperative 24-hour benefit of analgesia score (BCS) and patient-controlled intravenous analgesia (PCIA) pressing frequency. Secondary outcomes include postoperative pain scores, opioid consumption, and adverse events. This study aims to determine whether RISS block improves postoperative recovery and reduces opioid requirements after VATS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Sep 2024
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 5, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedMarch 10, 2026
March 1, 2026
1 year
March 5, 2026
March 5, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
24-hour cumulative number of effective PCA presses
Within 24 hours postoperatively
Bruggrmann Comfort Scale (BCS) score at 24 hours
24 hours after surgery
Study Arms (3)
RISS Block Group
EXPERIMENTALICNB Group
EXPERIMENTALControl Group
NO INTERVENTIONInterventions
Ultrasound-guided dual-plane RISS block performed after induction of general anesthesia. A total of 40 mL of 0.375% ropivacaine (150 mg) was administered across the rhomboid-intercostal plane and low subserratus plane.
Ultrasound-guided intercostal nerve block performed at surgical port levels (T4-T7) using 0.375% ropivacaine with total dose ≤75 mg.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- ASA physical status I-II
- Scheduled for elective video-assisted thoracoscopic surgery (VATS)
- Provided written informed consent
You may not qualify if:
- History of shock or coma
- Coagulopathy
- Local infection at the puncture site
- Pre-existing nerve injury on the side intended for block
- Chronic analgesic use
- Psychiatric disorders
- Prior thoracic or breast surgery
- Allergy to local or general anaesthetic agents
- Body mass index (BMI) ≥35 kg/m²
- Inability to operate a patient-controlled analgesia (PCA) device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Hospital of Ningbo University
Ningbo, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 5, 2026
First Posted
March 10, 2026
Study Start
September 1, 2024
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share